Dr. Reddy’s Hit With Class-Action Suit Claiming False Statements

Drug Industry Daily
A A
Dr. Reddy’s Laboratories said it will contest a class-action lawsuit by investors who claim the company made false or misleading statements about its quality system.

To View This Article:

Login

Subscribe To Drug Industry Daily